Scholtz & Company, LLC Invitae Corp Transaction History

Scholtz & Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$14.7 - $28.67 $199,479 - $389,051	-13,570 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $149,020 - $205,968	-6,130 Reduced 31.12%	13,570 $386,000
Q2 2021 Aug 09, 2021	BUY	$26.09 - $40.4 $124,318 - $192,506	4,765 Added 31.9%	19,700 $664,000
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $227,452 - $391,678	-6,880 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $33,226 - $48,790	850 Added 14.1%	6,880 $288,000
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $171,432 - $269,360	6,030 New	6,030 $261,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Scholtz & Company, LLC with notifications on news.